GlassScriptPhysician profile
Marilyn Jose
NPI 1083802441
$1,532.02
in general payments reported to CMS, 2019-2025
13 companies · $157 in 2025
The $157 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $190 · 2023: $737 · 2024: $320 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,213.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $439.14 | 2023-2024 | Injectafer |
| Astrazeneca Pharmaceuticals LP | $191.62 | 2023-2025 | Farxiga, Wainua |
| Impulse Dynamics (USA) INC. | $178.00 | 2023 | Optimizer |
| Mallinckrodt Hospital Products INC. | $122.17 | 2024 | Terlivaz |
| Abbott Laboratories | $110.57 | 2024-2025 | Cardiomems |
| Horizon Therapeutics Plc | $99.84 | 2022 | |
| Esperion Therapeutics, INC. | $99.78 | 2021 | |
| Alexion Pharmaceuticals, INC. | $89.78 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $72.05 | 2024-2025 | Uptravi, Opsumit |
| Scpharmaceuticals INC. | $52.19 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $43.04 | 2021-2025 | |
| Baxter Healthcare | $22.13 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Melinta Therapeutics, LLC | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marilyn Jose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.